Under Burjeel Holdings' management, the hospital will offer round-the-clock care across a range of outpatient specialities for the Abu Dhabi National Oil Company's (ADNOC) workforce and other ...

Burjeel Holdings has acquired an 80% stake in Dubai-based Advanced Care Oncology Center (ACOC) and plans to create a radiation oncology network in the Gulf Cooperation Council (GCC). ACOC provides ...

Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region and Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, today ...

Media: M Unnikrishnan Corporate Communications Officer Burjeel Holdings [email protected] M: +971504275895 Joseph Kemp Assistant Vice President, Public Relations Northwell Health Jkemp1 ...

The deal, for $46.3mn, will optimise the long-term cost structure and save the company nearly $93.4mn in long-term lease ...

About Burjeel Holdings. Founded in 2007, Burjeel Holdings is one of the leading private healthcare services providers in the UAE with a growing presence in Oman and the GCC.

MCLEAN, Va.& ABU DHABI, United Arab Emirates---- Claritev Corporation and Claims Care Revenue Cycle Management LLC, a division of Burjeel Holdings, are pleased to announce the formalization of ...

--Burjeel Holdings, one of the largest healthcare providers in the MENA region, and BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, ...

Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has announced its plan to establish the leading radiation oncology network in the GCC, following its successful ...

PALO ALTO, Calif. & ABU DHABI, United Arab Emirates, April 17, 2025--Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region and Hippocratic AI, the company that ...

Burjeel Holdings group CEO John Sunil said: “We are proud to strengthen our partnership with ADNOC through the management of the new Das Hospital.

Burjeel Holdings, one of the largest healthcare providers in the MENA region, and BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, have ...